Literature DB >> 20649938

The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.

Nai-Ying Yang, Pablo Lopez-Bergami, James S Goydos, Dana Yip, Ameae M Walker, Elena B Pasquale, Iryna M Ethell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20649938      PMCID： PMC2939943          DOI： 10.1111/j.1755-148X.2010.00745.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  12 in total

Review 1.  Clinical translation of angiogenesis inhibitors.

Authors:  Robert Kerbel; Judah Folkman
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

2.  Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway.

Authors:  Jena J Steinle; Cynthia J Meininger; Reza Forough; Guoyao Wu; Mack H Wu; Harris J Granger
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

Review 3.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

4.  Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.

Authors:  S Ram Kumar; Jasbir Singh; Guangbin Xia; Valery Krasnoperov; Loubna Hassanieh; Eric J Ley; Jeffrey Scehnet; Neil G Kumar; Debra Hawes; Michael F Press; Fred A Weaver; Parkash S Gill
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

5.  Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells.

Authors:  Stefanie Meyer; Christian Hafner; Markus Guba; Stefanie Flegel; Edward K Geissler; Bernd Becker; Gudrun E Koehl; Evelyn Orsó; Michael Landthaler; Thomas Vogt
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

6.  EphA2 as a promoter of melanoma tumorigenicity.

Authors:  Naira V Margaryan; Luigi Strizzi; Daniel E Abbott; Elisabeth A Seftor; M Sambasiva Rao; Mary J C Hendrix; Angela R Hess
Journal:  Cancer Biol Ther       Date:  2009-02-21       Impact factor: 4.742

7.  EphB4 overexpression in B16 melanoma cells affects arterial-venous patterning in tumor angiogenesis.

Authors:  Xiaoyong Huang; Yoshihiro Yamada; Hiroyasu Kidoya; Hisamichi Naito; Yumi Nagahama; Lingyu Kong; Shin-Ya Katoh; Weng-lin Li; Masaya Ueno; Nobuyuki Takakura
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

Review 8.  Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors.

Authors:  Angela R Hess; Naira V Margaryan; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Dev Dyn       Date:  2007-12       Impact factor: 3.780

Review 9.  Understanding signaling cascades in melanoma.

Authors:  Pablo Lopez-Bergami; Boris Fitchman; Ze'ev Ronai
Journal:  Photochem Photobiol       Date:  2007-12-15       Impact factor: 3.421

Review 10.  Melanoma biology and new targeted therapy.

Authors:  Vanessa Gray-Schopfer; Claudia Wellbrock; Richard Marais
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962
View more
  10 in total

1.  A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.

Authors:  Roberta Noberini; Surya K De; Ziming Zhang; Bainan Wu; Dhanya Raveendra-Panickar; Vida Chen; Jesus Vazquez; Haina Qin; Jianxing Song; Nicholas D P Cosford; Maurizio Pellecchia; Elena B Pasquale
Journal:  Chem Biol Drug Des       Date:  2011-09-06       Impact factor: 2.817

Review 2.  The Multiple Roles of Exosomes in Metastasis.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwen Kollmorgen; Rüdiger Rüger
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

3.  The role of EphB4 and IGF-IR expression in breast cancer cells.

Authors:  Gena Huang; Man Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  ROR2 promotes epithelial-mesenchymal transition by hyperactivating ERK in melanoma.

Authors:  María Victoria Castro; Gastón Alexis Barbero; Paula Máscolo; María Belén Villanueva; Jérémie Nsengimana; Julia Newton-Bishop; Edith Illescas; María Josefina Quezada; Pablo Lopez-Bergami
Journal:  J Cell Commun Signal       Date:  2022-06-20       Impact factor: 5.782

5.  Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.

Authors:  Srinivas Duggineni; Sayantan Mitra; Roberta Noberini; Xiaofeng Han; Nan Lin; Yan Xu; Wang Tian; Jing An; Elena B Pasquale; Ziwei Huang
Journal:  Biochem Pharmacol       Date:  2012-12-17       Impact factor: 5.858

6.  Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance.

Authors:  Chaohao Li; Nadia A Lanman; Yifan Kong; Daheng He; Fengyi Mao; Elia Farah; Yanquan Zhang; Jinghui Liu; Chi Wang; Qiou Wei; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

7.  PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.

Authors:  Roberta Noberini; Sayantan Mitra; Ombretta Salvucci; Fatima Valencia; Srinivas Duggineni; Natalie Prigozhina; Ke Wei; Giovanna Tosato; Ziwei Huang; Elena B Pasquale
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

8.  Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments.

Authors:  Christin Neuber; Birgit Belter; Sebastian Meister; Frank Hofheinz; Ralf Bergmann; Hans-Jürgen Pietzsch; Jens Pietzsch
Journal:  Molecules       Date:  2018-02-17       Impact factor: 4.411

9.  ROR2 has a protective role in melanoma by inhibiting Akt activity, cell-cycle progression, and proliferation.

Authors:  María Victoria Castro; Gastón Alexis Barbero; María Belén Villanueva; Luca Grumolato; Jérémie Nsengimana; Julia Newton-Bishop; Edith Illescas; María Josefina Quezada; Pablo Lopez-Bergami
Journal:  J Biomed Sci       Date:  2021-11-13       Impact factor: 8.410

10.  ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation.

Authors:  María Victoria Castro; Gastón Alexis Barbero; Paula Máscolo; Rocío Ramos; María Josefina Quezada; Pablo Lopez-Bergami
Journal:  Cell Mol Biol Lett       Date:  2022-03-08       Impact factor: 5.787
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.